+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Severe Acute Respiratory Syndrome"

Respiratory Disease Vaccine Global Market Report 2024 - Product Thumbnail Image

Respiratory Disease Vaccine Global Market Report 2024

  • Report
  • January 2024
  • 175 Pages
  • Global
From
COVID-19 Testing - Global Strategic Business Report - Product Thumbnail Image

COVID-19 Testing - Global Strategic Business Report

  • Report
  • May 2024
  • 1417 Pages
  • Global
From
COVID-19 Antigen Test Global Market Report 2024 - Product Thumbnail Image

COVID-19 Antigen Test Global Market Report 2024

  • Report
  • March 2024
  • 175 Pages
  • Global
From
Hospital-Acquired Infection Control Global Market Report 2024 - Product Thumbnail Image

Hospital-Acquired Infection Control Global Market Report 2024

  • Report
  • February 2024
  • 200 Pages
  • Global
From
From
From
Loading Indicator

Severe Acute Respiratory Syndrome (SARS) is a contagious respiratory illness caused by a virus. Diagnostics for SARS involve laboratory tests to detect the virus or its genetic material in a sample taken from the patient. Diagnostic tests for SARS include reverse transcription-polymerase chain reaction (RT-PCR), antigen-capture enzyme-linked immunosorbent assay (ELISA), and nucleic acid hybridization. These tests are used to detect the presence of the virus in a patient's sample and to differentiate between SARS and other respiratory illnesses. Diagnostics for SARS are important for early detection and treatment of the disease. Early diagnosis and treatment can reduce the severity of the illness and prevent its spread. Diagnostics for SARS are also used to monitor the spread of the virus and to track its evolution. Companies in the SARS diagnostics market include Abbott Laboratories, Becton Dickinson, Cepheid, Hologic, and Roche Diagnostics. Show Less Read more